SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical…...| LENZ Therapeutics, Inc.
| LENZ Therapeutics, Inc. (LENZ) Press Releases
| LENZ Therapeutics, Inc. (LENZ) Press Releases
| LENZ Therapeutics, Inc. (LENZ) Press Releases
| LENZ Therapeutics, Inc. (LENZ) Press Releases
| LENZ Therapeutics, Inc. (LENZ) Press Releases
| LENZ Therapeutics, Inc. (LENZ) Press Releases
| LENZ Therapeutics, Inc. (LENZ) Press Releases
| LENZ Therapeutics, Inc. (LENZ) Press Releases
LENZ Therapeutics is a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia.| LENZ Therapeutics, Inc.
VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia, a condition impacting…...| LENZ Therapeutics, Inc.